DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.24 billion.

GUIDANCE:

DexCom sees FY2026 revenue of $5.16-5.25 billion, versus the consensus of $5.23 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.